| Financial Year |
March 31 2023 |
| Monetary Funds |
461,116,404.86 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
25,851,801.65 |
| Accounts Receivable |
3,159,190,856.97 |
| Advances to Suppliers |
84,539,812.98 |
| Other Receivables |
71,755,647.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
87,377,807.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
69,999,396.22 |
| Total Current Assets |
5,859,266,359.88 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
298,862,818.19 |
| Investment Properties |
97,525,468.66 |
| Fixed Assetes |
854,028,675.47 |
| Under-construction Projects |
213,046,436.54 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
159,357,527.51 |
| R&D expenses |
-- |
| Goodwill |
156,924,978.92 |
| Long-Term Deferred and Prepaid Expenses |
5,317,296.34 |
| Deferred Income Tax Assets |
316,073,697.16 |
| Other Non-Current Assets |
92,917,121.85 |
| Sub-Total of Non-Current Assets |
2,227,403,363.09 |
| Total Assets |
8,086,669,722.97 |
| Short-Term Loans |
1,340,646,295.98 |
| Trading Financial liabilities |
-- |
| Notes Payable |
80,253,459.83 |
| Accounts Payable |
1,480,515,642.09 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
38,364,464.48 |
| Taxes Payable |
312,112,595.65 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
168,192,717.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
874,744,211.30 |
| Other Current Liabilities |
77,735,508.10 |
| Sub-Total of Current Liabilities |
4,527,190,354.34 |
| Long-term Loans |
-- |
| Bonds Payable |
583,783,601.19 |
| Long-Term Accounts Payable |
942,718.21 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
21,197,218.86 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
611,013,737.53 |
| Total Liabilities |
5,138,204,091.87 |
| Paid-In Capital(Or Share Stock) |
1,805,637,475.00 |
| Capital Surplus |
777,340,233.13 |
| Surplus Reserve |
115,182,184.16 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
147,452,909.36 |
| Minority Stockholder's Interest |
24,226,591.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,924,239,039.78 |
| Owner's Equity（Stockholder's Equity） |
2,948,465,631.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,086,669,722.97 |
